Ophthalmic Consultants of Long Island   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lynbrook NY United States (1997)

Organization Overview

First Clinical Trial
2006
NCT00333476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ophthalmic Consultans of Long Island | Ophthalmic Consultants of Long Island